Back

The impact of modulation of SNS activity on the evolution of heart failure and exercise capacity in patients with resistant hypertension and heart failure with preserved ejection fraction

13 May 2024 (09:00 - 10:00)
Organised by: Logo
Congress Presentation Part of: ePosters in chronic heart failure - treatment 7 Devices for Autonomic Modulation HFA Premium Access Heart Failure 2024 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Anna Moiseeva

Institute of Cardiology, Chisinau (Moldova (Republic of))

7 More presentations in this session

Presentation thumbnail
Favourable effect of transcutaneous vagus nerve stimulation on health-related quality of life in patients with heart failure and moderately reduced or preserved ejection fraction
Professor A. Bartoli (Milan, IT)
Abstract Slides Video
Presentation thumbnail
Characteristics of participants derived from direct-to-consumer vs. clinical referrals in the baroreflex activation therapy for heart failure (BeAT-HF) trial
Doctor R. Garcia (Charlotte, US)
Abstract Slides Video
Presentation thumbnail
Evaluation of the impact of heart failure pharmacist-led optimisation outpatient clinics at a tertiary hospital
Miss D. Keegan (London, GB)
Abstract Slides Video
Presentation thumbnail
Characteristics and treatment in a contemporary cohort of patients with heart failure followed in heart failure units in Spain.
Doctor J. Bonilla Palomas (Ubeda, ES)
Abstract Slides Video
Presentation thumbnail
The impact of an outpatient heart failure medical unit on patient functional capacity and quality of life
Doctor S. Costa Monteiro (Aveiro, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in chronic heart failure - treatment 7

The Event

Event poster

Heart Failure 2024

13 May 2024 09:00 CET
You may be interested in
thumbnail
Congress Session
Hottest trials (1)
thumbnail
Congress Session
Advances in heart failure detection and therapy
thumbnail
Congress Presentation
Pulmonary artery denervation clinical study using the gradient denervation system in heart failure patients with pulmonary hypertension group 2

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources